No abstract available
Keywords:
biomarker; cardiovascular disease; diabetes; dysbiosis; fatty liver disease; obesity.
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article. AIA-M obtained a postdoctoral contract (RPS 24665, 2021) from Consejería de Salud y Familias, Junta de Andalucía, Spain. JP-D is part of the “UGR Plan Propio de Investigación 2016” and the “Excellence actions: Unit of Excellence in Exercise and Health (UCEES), University of Granada.” RS receives financial support from the Second Century Fund (C2F), Chulalongkorn University.